acc01401 |
Transcription factor ETV6 |
phosphorylation |
Ser22 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01402 |
Protein phosphatase inhibitor 2 family member B |
phosphorylation |
Ser122 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01403 |
Protein phosphatase inhibitor 2 |
phosphorylation |
Ser122 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01404 |
"Lamina-associated polypeptide 2, isoform alpha" |
phosphorylation |
Ser66 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01405 |
Epidermal growth factor receptor substrate 15 |
phosphorylation |
Ser796 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01406 |
Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase |
phosphorylation |
Ser67 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01407 |
Transcriptional regulator ATRX |
phosphorylation |
Ser1291 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01408 |
Large proline-rich protein BAG6 |
phosphorylation |
Ser964 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01409 |
Microtubule-associated protein 1B |
phosphorylation |
Ser1016 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01410 |
Microtubule-associated protein 1B |
phosphorylation |
Ser1256 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01411 |
Microtubule-associated protein 1B |
phosphorylation |
Ser1154 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01412 |
Microtubule-associated protein 1B |
phosphorylation |
Ser1782 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01413 |
Microtubule-associated protein 1B |
phosphorylation |
Ser832 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01414 |
Microtubule-associated protein 1B |
phosphorylation |
Ser1396 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01415 |
Microtubule-associated protein 1B |
phosphorylation |
Ser1400 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01416 |
Cytosolic phospholipase A2 |
phosphorylation |
Ser437 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01417 |
Nestin |
phosphorylation |
Ser680 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01418 |
Nuclear autoantigenic sperm protein |
phosphorylation |
Ser480 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01419 |
Choline-phosphate cytidylyltransferase A |
phosphorylation |
Ser319 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01420 |
RNA-binding protein 25 |
phosphorylation |
Ser703 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01421 |
E3 SUMO-protein ligase RanBP2 |
phosphorylation |
Ser2280 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01422 |
RanBP2-like and GRIP domain-containing protein 4 |
phosphorylation |
Ser1305 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01423 |
Double-strand break repair protein MRE11 |
phosphorylation |
Ser688 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01424 |
Double-strand break repair protein MRE11 |
phosphorylation |
Ser689 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01425 |
PDZ and LIM domain protein 4 |
phosphorylation |
Ser112 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01426 |
Hsc70-interacting protein |
phosphorylation |
Ser79 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01427 |
Putative protein FAM10A4 |
phosphorylation |
Ser75 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01428 |
Amiloride-sensitive sodium channel subunit beta |
phosphorylation |
Ser633 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01429 |
Amiloride-sensitive sodium channel subunit beta |
phosphorylation |
Ser635 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01430 |
Death-associated protein 1 |
phosphorylation |
Ser51 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01431 |
Transcription activator BRG1 |
phosphorylation |
Ser1631 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01432 |
Transcription activator BRG1 |
phosphorylation |
Ser1570 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01433 |
Transcription activator BRG1 |
phosphorylation |
Ser660 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01434 |
Transcription activator BRG1 |
phosphorylation |
Ser662 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01435 |
Hepatoma-derived growth factor |
phosphorylation |
Ser165 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01436 |
DNA mismatch repair protein Msh6 |
phosphorylation |
Ser254 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01437 |
DNA mismatch repair protein Msh6 |
phosphorylation |
Ser227 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01438 |
DNA mismatch repair protein Msh6 |
phosphorylation |
Ser137 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01439 |
High mobility group protein HMGI-C |
phosphorylation |
Ser44 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01440 |
Nuclear pore complex protein Nup98-Nup96 |
phosphorylation |
Ser934 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01441 |
Activated RNA polymerase II transcriptional coactivator p15 |
phosphorylation |
Ser10 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01442 |
Activated RNA polymerase II transcriptional coactivator p15 |
phosphorylation |
Ser19 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01443 |
Methylosome subunit pICln |
phosphorylation |
Ser102 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01444 |
Microfibrillar-associated protein 1 |
phosphorylation |
Ser133 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01445 |
Microfibrillar-associated protein 1 |
phosphorylation |
Ser116 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01446 |
Microfibrillar-associated protein 1 |
phosphorylation |
Ser118 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01447 |
Microfibrillar-associated protein 1 |
phosphorylation |
Ser53 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01448 |
Double-stranded RNA-specific adenosine deaminase |
phosphorylation |
Ser825 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01449 |
Histone deacetylase 4 |
phosphorylation |
Ser565 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01450 |
Protein max |
phosphorylation |
Ser11 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|